abstract |
Isolated human monoclonal antibodies and other proteins, which bind to human IL-21, and related antibody-based compositions and molecules, are disclosed. Also disclosed are pharmaceutical compositions comprising the human antibodies, and therapeutic and diagnostic methods for using the human antibodies, proteins, and other molecules. |